The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Protein phosphatase 2A subunit assembly: the catalytic subunit carboxy terminus is important for binding cellular B subunit but not polyomavirus middle tumor antigen
Abstract
The carboxy terminus of protein phosphatase 2A (PP2A) catalytic subunit is highly conserved. Seven out of the last nine residues, including two potential in vivo phosphorylation sites, threonine 304 and tyrosine 307, are completely invariant in all known PP2As. Mutational analysis of the carboxy terminus in vivo was facilitated by efficient immunoprecipitation of trimeric PP2A holoenzyme via an epitope-tagged catalytic subunit. The results indicate that the catalytic subunit carboxy terminus is important for complex formation with the PP2A 55 kDa regulatory B subunit, but not with polyomavirus oncogene, middle tumor antigen (MT), a viral B-type regulatory subunit. Replacing catalytic subunit threonine 304 or tyrosine 307 with a negatively charged amino acid abolished binding of the B subunit to the dimeric enzyme core and altered substrate specificity. Certain other amino acid substitutions of different size and/or charge also abolished or greatly reduced B subunit binding. Substitution of alanine at position 304 or phenylalanine at position 307 did not dramatically reduce B subunit binding or phosphatase activity in vitro, yet the latter substitutions are not found in naturally occurring PP2As. Thus, the wild-type residues are important for a yet unknown function in vivo. Additionally, deleting the carboxy terminal nine amino acids inhibited binding of the B subunit to the dimeric enzyme core, indicating a requirement for one or more of these amino acids for complex formation. MT interaction with the dimeric PP2A enzyme core was not inhibited by any of these mutations. Finally, unlike B subunit, MT does not activate the phosphatase activity of the PP2A heterodimer towards cdc2-phosphorylated histone H1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, mutation and deletion of a small region in the C-terminal tail (residues 304–309) was found to abrogate binding between B55 and the core enzyme (Ogris et al., 1997).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Ogris et al., 1997
In the citing paper
“Initial studies have pointed to the reversible methylation of a specific residue (L309) at the C-terminal tail of the catalytic subunit [ 63 – 65 ]. This modification appears to be critical in modulating the binding affinity of the regulatory subunit, contributing to the formation of distinct heterotrimeric complexes.”
From Targeting PP2A in cancer: an underrated option (2025) · cites this paper as [63]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Flagged first, then by citations
Cited by
Sorted by citations
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,927
Serine/threonine phosphatases: mechanism through structure
Shi, Y. (2009) · Cell · doi:10.1016/j.cell.2009.10.006 · Cited by 1,488
Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme
Cho, U. S., & Xu, W. (2007) · Nature · doi:10.1038/nature05351 · Cited by 459
PP2A holoenzyme assembly: In cauda venenum (the sting is in the tail)
Janssens, V., Longin, S., & Goris, J. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.004 · Cited by 390
Protein phosphatase 2A: the Trojan Horse of cellular signaling
Sontag, E. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00123-6 · Cited by 330
All roads lead to PP 2A: exploiting the therapeutic potential of this phosphatase
Sangodkar, J., Farrington, C. C., McClinch, K., Galsky, M. D., Kastrinsky, D. B., & Narla, G. (2016) · The FEBS Journal · doi:10.1111/febs.13573 · Cited by 312
Nunbhakdi‐Craig, V., Machleidt, T., Ogris, E., Bellotto, D. J., White, C. L., & Sontag, E. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200206114 · Cited by 266
Self-citationInvolvement of PP2A in viral and cellular transformation
Arroyo, J. D., & Hahn, W. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209038 · Cited by 237
Tolstykh, T., Lee, J., Vafai, S. B., & Stock, J. B. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5682 · Cited by 239
Letourneux, C., Rocher, G., & Porteu, F. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600980 · Cited by 224
Bennin, D. A., Don, A. S. A., Brake, T., McKenzie, J. L., Rosenbaum, H., Ortiz, L., DePaoli-Roach, A. A., & Horne, M. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111693200 · Cited by 215
Structural mechanism of demethylation and inactivation of protein phosphatase 2A
Xing, Y., Li, Z., Chen, Y., Stock, J. B., Jeffrey, P. D., & Shi, Y. (2008) · Cell · doi:10.1016/j.cell.2008.02.041 · Cited by 206
Moreno, C. S., Park, S., Nelson, K., Ashby, D., Hubalek, F., Lane, W. S., & Pallas, D. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5257 · Cited by 194
Self-citationIdentification of PP2A Complexes and Pathways Involved in Cell Transformation
Sablina, A. A., Hector, M., Colpaert, N., & Hahn, W. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2855 · Cited by 193
Ogris, E., Du, X., Nelson, K. C., Mak, E. K., Yu, X. X., Lane, W. S., & Pallas, D. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14382 · Cited by 191
Self-citationSontag, E., Hladik, C. L., Montgomery, L. G., Luangpirom, A., Mudrak, I., Ogris, E., & White, C. L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.10.1080 · Cited by 195
Self-citationLongin, S., Zwaenepoel, K., Louis, J. V., Dilworth, S., Goris, J., & Janssens, V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704059200 · Cited by 184
Lessons in Signaling and Tumorigenesis from Polyomavirus Middle T Antigen
Fluck, M. M., & Schaffhausen, B. S. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00009-09 · Cited by 186
BRYANT, J. C., Westphal, R. S., & Wadzinski, B. E. (1999) · Biochemical Journal · doi:10.1042/bj3390241 · Cited by 173
Regulation and Function of Protein Kinases and Phosphatases
Cheng, H., Qi, R. Z., Paudel, H. K., & Zhu, H. (2011) · Enzyme Research · doi:10.4061/2011/794089 · Cited by 179
α4 Is an Essential Regulator of PP2A Phosphatase Activity
Kong, M., Ditsworth, D., Lindsten, T., & Thompson, C. B. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.025 · Cited by 162
Yu, X. X., Du, X., Moreno, C. S., Green, R. E., Ogris, E., Feng, Q., Chou, L., McQuoid, M. J., & Pallas, D. C. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.185 · Cited by 160
Self-citationThe structural basis for tight control of PP2A methylation and function by LCMT-1
Stanevich, V., Jiang, L., Satyshur, K. A., Li, Y., Jeffrey, P. D., Li, Z., Menden, P., Semmelhack, M. F., & Xing, Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2010.12.030 · Cited by 142
Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation
Wang, Y., Yang, R., Gu, J., Yin, X., Jin, N., Xie, S., Wang, Y., Chang, H., Qian, W., Shi, J., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.035 · Cited by 134
Wei, H., Ashby, D. G., Moreno, C. S., Ogris, E., Yeong, F. M., Corbett, A. H., & Pallas, D. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008694200 · Cited by 128
Self-citationXiong, Y., Jing, X.-P., Zhou, X.-W., Wang, X.-L., Yang, Y., Sun, X.-Y., Qiu, M., Cao, F.-Y., Lu, Y.-M., Liu, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.07.003 · Cited by 122
Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
Kauko, O., & Westermarck, J. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.01.005 · Cited by 111
Dunagan, M., Chaudhry, K., Samak, G., & Rao, R. K. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00526.2011 · Cited by 103
Hill, T. A., Stewart, S. G., Sauer, B., Gilbert, J., Ackland, S. P., Sakoff, J. A., & McCluskey, A. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.093 · Cited by 103
Longin, S., Jordens, J., MARTENS, E., Stevens, I., Janssens, V., Rondelez, E., BAERE, I. D., Derua, R., Waelkens, E., Goris, J., et al. (2004) · Biochemical Journal · doi:10.1042/bj20031643 · Cited by 106
Gordon, J., Hwang, J., Carrier, K., Jones, C. A., Kern, Q. L., Moreno, C. S., Karas, R. H., & Pallas, D. C. (2011) · BMC Biochemistry · doi:10.1186/1471-2091-12-54 · Cited by 101
Self-citationStructural basis of PP2A activation by PTPA, an ATP-dependent activation chaperone
Guo, F., Stanevich, V., Wlodarchak, N., Sengupta, R., Jiang, L., Satyshur, K. A., & Xing, Y. (2014) · Cell Research · doi:10.1038/cr.2013.138 · Cited by 100
Goedert, M., Satumtira, S., Jakes, R., Smith, M. J., Kamibayashi, C., White, C. L., & Sontag, E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752155.x · Cited by 102
Moreno, C. S., Lane, W. S., & Pallas, D. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102398200 · Cited by 95
Self-citationYeong, F. M., Hombauer, H., Wendt, K. S., Hirota, T., Mudrak, I., Mechtler, K., Loregger, T., Marchler‐Bauer, A., Tanaka, K., Peters, J., et al. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.032 · Cited by 94
Self-citationPP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2019.03.009 · Cited by 93
Elder, R. T., Yu, M., Chen, M., Zhu, X., Yanagida, M., & Zhao, Y. (2001) · Virology · doi:10.1006/viro.2001.1007 · Cited by 92
Reilein, A. R., Tint, I. S., Peunova, N. I., Enikolopov, G., & Gelfand, V. I. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.803 · Cited by 92
Determinants for Substrate Specificity of Protein Phosphatase 2A
Slupe, A. M., Merrill, R. A., & Strack, S. (2011) · Enzyme Research · doi:10.4061/2011/398751 · Cited by 91
Plant protein phosphatases: What do we know about their mechanism of action?
Bheri, M., Mahiwal, S., Sanyal, S. K., & Pandey, G. K. (2020) · FEBS Journal · doi:10.1111/febs.15454 · Cited by 81
Li, Y., Yue, P., Deng, X., Ueda, T., Fukunaga, R., Khuri, F. R., & Sun, S. (2010) · Neoplasia · doi:10.1593/neo.10704 · Cited by 78
Sacharidou, A., Chambliss, K. L., Ulrich, V., Salmon, J. E., Shen, Y.-M. P., Herz, J., Hui, D. Y., Terada, L. S., Shaul, P. W., & Mineo, C. (2018) · Blood · doi:10.1182/blood-2017-11-814681 · Cited by 78
Sontag, J., Nunbhakdi‐Craig, V., Montgomery, L. G., Arning, E., Bottiglieri, T., & Sontag, E. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2816-08.2008 · Cited by 77
Palanichamy, K., Kanji, S., Gordon, N., Thirumoorthy, K., Jacob, J. R., Litzenberg, K. T., Patel, D., & Chakravarti, A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1323 · Cited by 76
Sontag, J., Nunbhakdi‐Craig, V., White, C. L., Halpain, S., & Sontag, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338681 · Cited by 79
Nunbhakdi‐Craig, V., Schüchner, S., Sontag, J., Montgomery, L. G., Pallas, D. C., Juno, C., Mudrak, I., Ogris, E., & Sontag, E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04503.x · Cited by 72
Self-citationTerentyev, D. A., Rees, C. M., Li, W., Cooper, L. L., Jindal, H. K., Peng, X., Lu, Y., Terentyeva, R., Odening, K. E., Daley, J. M., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.305146 · Cited by 71
Lee, J. A., & Pallas, D. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704861200 · Cited by 69
Self-citationShtrichman, R., Sharf, R., & Kleinberger, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203705 · Cited by 68
B Vitamin Deficiency Promotes Tau Phosphorylation Through Regulation of GSK3β and PP2A
Nicolia, V., Fuso, A., Cavallaro, R. A., Luzio, A. D., & Scarpa, S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1284 · Cited by 67
Elgenaidi, I. S., & Spiers, P. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.011 · Cited by 67
Cytosolic Arl2 Is Complexed with Cofactor D and Protein Phosphatase 2A
Shern, J. F., Sharer, J. D., Pallas, D. C., Bartolini, F., Cowan, N. J., Reed, M. S., Pohl, J., & Kahn, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308678200 · Cited by 61
Self-citationJackson, J. B., & Pallas, D. C. (2012) · Neoplasia · doi:10.1593/neo.12768 · Cited by 60
Self-citationGuergnon, J., Godet, A. N., Galioot, A., Falanga, P. B., Colle, J., Cayla, X., & Garcı́a, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.001 · Cited by 62
Chen, C., Lin, C., Chiang, C.-W., Jan, M., & Lin, Y.-S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024059 · Cited by 58
Spatial control of protein phosphatase 2A (de)methylation
Longin, S., Zwaenepoel, K., Martens, E., Louis, J. V., Rondelez, E., Goris, J., & Janssens, V. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.030 · Cited by 59
Protein Phosphatase 2A as a Potential Target for Anticancer Therapy
Kalev, P., & Sablina, A. A. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011794941172 · Cited by 58
Nicholls, R. E., Sontag, J.-M., Zhang, H., Staniszewski, A., Yan, S., Kim, C. Y., Yim, M., Woodruff, C. M., Arning, E., Wasek, B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521018113 · Cited by 56
Hwang, J., Lee, J. A., & Pallas, D. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739920 · Cited by 56
Self-citationThe role of serine/threonine protein phosphatases in exocytosis
Sim, A. T. R., Baldwin, M. L., Rostas, J. A. P., Holst, J., & Ludowyke, R. I. (2003) · Biochemical Journal · doi:10.1042/bj20030484 · Cited by 56
Assembly and structure of protein phosphatase 2A
Shi, Y. (2009) · Science in China Series C Life Sciences · doi:10.1007/s11427-009-0018-3 · Cited by 56
Raman, D., & Pervaiz, S. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101105 · Cited by 58
Sontag, J., Nunbhakdi‐Craig, V., Mitterhuber, M., Ogris, E., & Sontag, E. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07049.x · Cited by 57
Self-citationProtein Phosphatase 2A Suppresses MAP Kinase Signalling and Ectopic Protein Expression
Chung, H., & Brautigan, D. L. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(99)00033-9 · Cited by 52
Ortega-Gutiérrez, S., Leung, D., Ficarro, S., Peters, E. C., & Cravatt, B. F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002486 · Cited by 50
Schaffhausen, B. S., & Roberts, T. M. (2008) · Virology · doi:10.1016/j.virol.2008.09.042 · Cited by 53
Bottiglieri, T., Arning, E., Wasek, B. L., Nunbhakdi‐Craig, V., Sontag, J. M., & Sontag, E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0125-12.2012 · Cited by 47
A Pak1-PP2A-ERM signaling axis mediates F-actin rearrangement and degranulation in mast cells
Staser, K. W., Shew, M. A., Michels, E. G., Mwanthi, M., Yang, F., Clapp, D. W., & Park, S.-J. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.10.001 · Cited by 46
Methylation-regulated decommissioning of multimeric PP2A complexes
Wu, C.-G., Zheng, A., Jiang, L., Rowse, M., Stanevich, V., Chen, H., Li, Y., Satyshur, K. A., Johnson, B., Gu, T.-J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02405-3 · Cited by 45
Ogris, E., Mudrak, I., Mak, E. K., Gibson, D., & Pallas, D. C. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7390-7398.1999 · Cited by 45
Self-citationGentry, M. S., Li, Y., Wei, H., Syed, F. F., Patel, S. H., Hallberg, R. L., & Pallas, D. C. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.6.1029-1040.2005 · Cited by 45
Self-citationFaulkner, N. E., Hilfinger, J. M., & Markovitz, D. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006454200 · Cited by 42
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
Padi, S. K. R., Vos, M. R., Godek, R. J., Fuller, J. R., Kruse, T., Hein, J. B., Nilsson, J., Kelker, M. S., Page, R., & Peti, W. (2023) · Nature · doi:10.1038/s41586-023-06870-3 · Cited by 39
Altered phosphorylation of cytoskeletal proteins in mutant protein phosphatase 2A transgenic mice
Schild, A., Ittner, L. M., & Götz, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.066 · Cited by 38
Prickett, T. D., & Brautigan, D. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401444200 · Cited by 37
Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small molecules
Haanen, T. J., O’Connor, C. M., & Narla, G. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102656 · Cited by 38
Yu, R. M. K., Wong, M. M. L., Jack, R. W., & Kong, R. Y. C. (2005) · Planta · doi:10.1007/s00425-005-0018-x · Cited by 35
Smetana, J. H. C., & Zanchin, N. I. T. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06112.x · Cited by 35
GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner
Chu, D., Tan, J., Xie, S.-T., Jin, N., Yin, X., Gong, C., Iqbal, K., & Liu, F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150497 · Cited by 35
Frohner, I. E., Mudrak, I., Kronlachner, S., Schüchner, S., & Ogris, E. (2020) · Science Signaling · doi:10.1126/scisignal.aax6490 · Cited by 34
Self-citationKurimchak, A., & Graña, X. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985069 · Cited by 33
Han, E. H., Petrella, D. P., & Blakeslee, J. J. (2017) · Journal of Experimental Botany · doi:10.1093/jxb/erx127 · Cited by 33
Deshmukh, P. A., Blunt, B. C., & Hofmann, P. A. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00225.2006 · Cited by 32
Inhibition of Src by direct interaction with protein phosphatase 2A
Yokoyama, N. N., & Miller, W. T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02874-5 · Cited by 31
Zhao, L., Li, R., & Gan, Y.-H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0774-8 · Cited by 30
A New Role for Protein Methylation: Switching Partners at the Phosphatase Ball
Mumby, M. C. (2001) · Science Signaling · doi:10.1126/stke.2001.79.pe1 · Cited by 31
Nasa, I., Cressey, L. E., Kruse, T., Hertz, E. P. T., Gui, J., Graves, L. M., Nilsson, J., & Kettenbach, A. N. (2020) · Science Signaling · doi:10.1126/scisignal.aba7823 · Cited by 28
Regulation of PP2A, PP4, and PP6 holoenzyme assembly by carboxyl-terminal methylation
Lyons, S. P., Greiner, E. C., Cressey, L. E., Adamo, M. E., & Kettenbach, A. N. (2021) · Scientific Reports · doi:10.1038/s41598-021-02456-z · Cited by 27
Mast cell function: Regulation of degranulation by serine/threonine phosphatases
Sim, A. T. R., Ludowyke, R. I., & Verrills, N. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.011 · Cited by 25
Neale, D. B., Morris, J. C., Verrills, N. M., & Ammit, A. J. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108834 · Cited by 25
Frohner, I. E., Mudrak, I., Schüchner, S., Anrather, D., Hartl, M., Sontag, J., Sontag, E., Wadzinski, B. E., Preglej, T., Ellmeier, W., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.035 · Cited by 22
Self-citationEffects of carboxyl-terminal methylation on holoenzyme function of the PP2A subfamily
Nasa, I., & Kettenbach, A. N. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200177 · Cited by 22
PP2A-B55 Holoenzyme Regulation and Cancer
Goguet-Rubio, P., Amin, P., Awal, S., Vigneron, S., Charrasse, S., Méchali, F., Labbé, J. C., Lorca, T., & Castro, A. (2020) · Biomolecules · doi:10.3390/biom10111586 · Cited by 21
The structure of the PP2A regulatory subunit B56γ: The remaining piece of the PP2A jigsaw puzzle
Magnúsdóttir, A., Stenmark, P., Flodin, S., Nyman, T., Kotenyova, T., Gräslund, S., Ogg, D., & Nordlund, P. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22150 · Cited by 20
Protein Phosphatase 2A (PP2A) Regulates EG5 to Control Mitotic Progression
Liu, Y., Zhang, Z., Liang, H., Zhao, X., Liang, L., Wang, G., Yang, J., Jin, Y., McNutt, M. A., & Yin, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-01915-w · Cited by 21
Mechanisms of the Scaffold Subunit in Facilitating Protein Phosphatase 2A Methylation
Stanevich, V., Zheng, A., Guo, F., Jiang, L., Wlodarchak, N., & Xing, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086955 · Cited by 20
White, D. W., & Tartaglia, L. A. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990501)73:2 · Cited by 68
Evans, D. R., & Hemmings, B. A. (2000) · Genetics · doi:10.1093/genetics/156.1.21 · Cited by 20
Impaired development of the Harderian gland in mutant protein phosphatase 2A transgenic mice
Schild, A., Isenmann, S., Tanimoto, N., Tonagel, F., Seeliger, M. W., Ittner, L. M., Kretz, A., Ogris, E., & Götz, J. (2006) · Mechanisms of Development · doi:10.1016/j.mod.2006.03.003 · Cited by 17
Self-citationFinnegan, S., Mackey, A. M., & Cotter, T. G. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07301.x · Cited by 16
Metadata
- Authors
- Ogris, E., Gibson, D. M., & Pallas, D. C.
- Affiliations
- Harvard University (US)
- University of Vienna (AT)
- Venue
- Oncogene
- Published
- 1997-08-21
- Volume
- 15
- Issue
- 8
- Pages
- 911-917
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2325151665
- Cited by
- 134
- References
- 1
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 5 · 2013: 3 · 2012: 9
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA57327, R01CA057327)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- protein phosphatase 2A, protein-protein binding, phosphatase substrate specificity, phosphatase activation
- MeSH terms
- Animals, Antigens, Neoplasm, Antigens, Viral, Binding Sites, Phosphoprotein Phosphatases, Phosphorylation, Polyomavirus, Precipitin Tests, Substrate Specificity, Threonine, Tyrosine, Mutagenesis, Site-Directed, 3T3 Cells, Mice, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review